Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster in Healthy Adults
NCT07640308Phase 1Not yet recruiting
- Sponsor
- Immunobiological Technology Institute
- Start
- Jul 2026
- Primary completion
- Jul 2027
01
Overview
Phase 1, open-label trial in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Immunobiological Technology Institute. Primary endpoint: Safety outcomes following experimental vaccination at 7 days. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07640308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640308.